235 related articles for article (PubMed ID: 17664254)
1. A pharmacogenomics primer.
Court MH
J Clin Pharmacol; 2007 Sep; 47(9):1087-103. PubMed ID: 17664254
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics - therapeutic and ethical issues.
Patowary S
Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
[TBL] [Abstract][Full Text] [Related]
3. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
Wang SJ
Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
[TBL] [Abstract][Full Text] [Related]
4. Implications of pharmacogenomics for anesthesia providers.
Ama T; Bounmythavong S; Blaze J; Weismann M; Marienau MS; Nicholson WT
AANA J; 2010 Oct; 78(5):393-9. PubMed ID: 21067087
[TBL] [Abstract][Full Text] [Related]
5. SNPs and haplotypes: genetic markers for disease and drug response (review).
Shastry BS
Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
7. Regulatory agency consideration of pharmacogenomics.
Pendergast MK
Exp Biol Med (Maywood); 2008 Dec; 233(12):1498-503. PubMed ID: 18849547
[TBL] [Abstract][Full Text] [Related]
8. Measuring the value of pharmacogenomics.
Phillips KA; Van Bebber SL
Nat Rev Drug Discov; 2005 Jun; 4(6):500-9. PubMed ID: 15915153
[TBL] [Abstract][Full Text] [Related]
9. Ethics and policy perspectives on personalized medicine in the post-genomic era.
Landon MR
J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics: bench to bedside.
Weinshilboum R; Wang L
Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
[TBL] [Abstract][Full Text] [Related]
12. Translating pharmacogenomics: challenges on the road to the clinic.
Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic discovery approaches: will the real genes please stand up?
Walgren RA; Meucci MA; McLeod HL
J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic applications in clinical drug development.
Dracopoli NC
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
16. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics--the potential of genetically guided prescribing.
Singh A
Aust Fam Physician; 2007 Oct; 36(10):820-4. PubMed ID: 17925902
[TBL] [Abstract][Full Text] [Related]
18. Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.
Frueh FW
Pharmacogenomics; 2010 May; 11(5):657-60. PubMed ID: 20415556
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing in clinical practice.
Lamberts SW; Uitterlinden AG
Annu Rev Med; 2009; 60():431-42. PubMed ID: 18947300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
